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1. Background
1.1 The urinary tract
Food is the main source of energy and nutrients for the human body. When cells consume
the nutrients, they also produce waste that must be removed. The system in the body that
removes waste is called the urinary tract system. This system works by filtering blood and
turning it into urine [1]. Within the urinary tract are the kidneys, which are two fist sized organs
located on each side of the spine. The kidneys receive a high volume of blood everyday,
approximately 120-150 quarts [1]. Using specialized blood vessels, the kidneys filter the blood
by turning waste and toxins into urine. The kidneys typically produce 1-2 quarts of urine
everyday [1]. Once the urine is produced, it travels down the ureters, which are thin tubes of
muscle approximately 4 mm in diameter. [1]. There are two ureters that connect each kidney to
both sides of the bladder. The bladder is a hollow, muscular organ that can hold up to 1.5 to 2
cups of urine [1]. As the bladder fills, signals are sent to the brain to notify the individual to
empty their bladder [1]. The urine, consisting of toxins and waste, gets emptied through the
urethra located at the bottom of the bladder. A figure representing the urinary tract system is
located below in Figure 1.
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Figure 1: The urinary tract including the kidneys, the ureters, the bladder, and the urethra [2].

1.2 Kidney Stones
There is a risk of developing kidney stones when the urine has high volumes of minerals
and salts, the most common being calcium. These substances can harden and form into clumps
which become lodged in the kidney and/or ureters. There are many factors that put an individual
at risk for developing kidney stones including urine volume, diet, obesity, or certain medical
conditions. One of the more common risk factors is a low urine volume which means an
individual produces less urine than normal. Low urine volume can result from dehydration,
exercise, or not drinking enough fluids. As a result, there is not enough fluid to keep minerals
and salts dissolved in the urine, which can lead to developing kidney stones. [3] Another risk
factor is a high salt volume diet. If there is an excess amount of salt in the urine, calcium cannot
be reabsorbed by the urine [3]. This causes increased levels of calcium in the urine resulting in a
higher chance of developing calcium kidney stones [3]. In addition to calcium stones, there are
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uric acid stones, struvite stones, and cystine stones [3]. In general, kidney stones are more
common in men than women and also in obese versus normal-weight indivuals [4].
The size of the kidney stone determines whether the stone can be passed naturally or
whether surgical treatment is required. It has been found that 95% of ureteral stones ranging
from 1.5-4 mm can be passed naturally [5]. The chances of the stones passing naturally drop to
about 50% when they are greater than 5 mm [5]. For stones that are greater than 7 mm, surgical
intervention is required [5, 6]. In the cases where surgery is required, the large stone is
fragmented into smaller fragments that range from 1.5-4 mm.

1.3 Types of procedures
There are numerous procedures that are used to fragment a large kidney stone into
smaller fragments. These include extracorporeal shock wave lithotripsy (ESWL), percutaneous
nephrolithotomy, and ureteroscopic holmium laser lithotripsy [7, 8]. An ESWL procedure can be
performed on stones located in either the kidney or the ureter. During an ESWL procedure high
energy shock waves, typically ultrasound waves or X-rays, are used to break up the large stone
into smaller fragments, which are then left to be passed naturally [1].
A percutaneous nephrolithotomy is performed on stones located only in the kidney.
During this procedure a nephroscope is inserted into a small incision in the patient's back [1].
The nephroscope then locates the stone in the kidney and removes it via an extraction device [1].
In some cases when a stone is too large to be extracted, it will be fragmented by a laser.
The final procedure is the ureteroscopic holmium laser lithotripsy, which is the procedure
our group has focused on in developing a new device. The ureteroscopic holmium laser
lithotripsy is performed on kidney stones greater than 4 mm located only in the ureter [9].
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Approximately 25% of all kidney stone removal procedures are performed using the holmium
laser lithotripsy technique [10]. This procedure uses an instrument called a ureteroscope, which
is a long thin tube consisting of an eyepiece on one end and a tiny light and lens on the other end,
shown Figure 2a [10]. The diameter of the ureteroscope ranges from 4.5Fr - 8.5Fr, where 1Fr =
⅓ mm, depending on the rigidity of the scope [5]. The ureteroscope also has multiple ports, of
diameter 3.6Fr, in which a laser and extraction device can be inserted independently of one
another, shown in Figure 2b [5].
(a)

(b)

Figure 2: a) The common ureteroscope with eyepiece on one end and light and lens on the other end [11].
b) The common ureteroscope with dimensions and working channels [12].

During the procedure, the ureteroscope is inserted through the urethra of the patient and travels
up through the bladder until it reaches the location of the stone in the ureter. Once the stone is
located, the flexible holmium laser is inserted through a port on the ureteroscope and aims laser
beams at the stone at a frequency of 10MHz and energy settings ranging from 30-140 mJoules
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[13]. This ruptures the large stone into smaller fragments which can then be extracted via an
extraction tool. The current extraction tools that are used with the laser produce further
complications, such as reinsertion of the device into the patient multiple times and the loss of
stones when the tool has reached the bladder. These complications will be addressed with our
improved device. An overview image of a holmium laser lithotripsy is shown below in Figure 3.

Figure 3: Holmium laser lithotripsy using a ureteroscope with a working channel for an extraction device to capture
the kidney stone [14].

1.4 Current Technology
The most common extraction device used with the laser is the wire basket that can be
shown below in Figure 4. The basket is composed of intertwined wires that form into a helical
shape. These wires can expand and contract using a sliding button which determines the size of
the basket. Once the laser has finished rupturing the large stone into tiny fragments, the basket
device is inserted through the scope port. While in the scope, the wire basket tip is contained
inside an outer sheath. When the basket has reached the fragments, the basket gets deployed out
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of the sheath by pushing a slider button down into its open position. When the slider button is
pushed up into the closed position, the basket can collapse and fit back into the sheath. The
adjustable size of the basket also allows different sized stones to be collected. The drawback with
the basket device is that it can only capture one stone at a time. Since the procedure produces
multiple stone fragments, the surgeon must repeatedly insert the device into the ureter to gather
each stone fragment. This technique can be time consuming, thus prolonging the surgery. A
figure of the basket device inside of the scope port is shown below in Figure 4.

Figure 4: Ureteroscope with zoomed-in image of the ports with the laser and the currently used basket device [15].

Another type of extraction device used during the procedure is called the NTrap which is
shown below in Figure 5 [16]. The NTrap is a flexible half spherical net composed of intertwined
wires. The NTrap is different from the basket in that it is placed in the ureter before
fragmentation. While the NTrap is in the scope port, it is contained in an outer sheath, similar to
the basket. When the NTrap reaches the fragments, the NTrap can deploy out of the sheath and
take on its full shape. The reason the NTrap is placed before fragmentation is that it blocks the
upstream of the ureter so no fragments travel past their initial location during fragmentation.
Once the stone is ruptured, the NTrap device gets pulled out through the ureter while collecting
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all of the fragments simultaneously. The drawback of the NTrap is that once the device reaches
the bladder, the fragments disperse and are lost in the bladder. This results in the patient having
to pass the fragments naturally. Our group decided to focus on innovating the NTrap for this
reason. If the NTrap had some mechanism that prevented the fragments from dispersing in the
bladder, it would efficiently collect all fragments with only one insertion, which addresses the
issue of the basket. Additionally, the innovated NTrap would decrease the duration of the
procedure since the removal of all fragments would be done with only one insertion. An image
of the NTrap device is shown below in Figure 5.

Figure 5: The NTrap extraction device [16].

2. Problem Statement
Every year kidney stones affect 654,000 Americans and 25% of these cases require a
ureteroscopy, which is performed on patients with kidney stones greater than 4 mm in the ureter
[4, 6]. A holmium laser is used to rupture the kidney stone resulting in fragmentation of the
stone. If not removed, these residual fragments can cause pain and may require a secondary
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procedure to remove them. The most common method for removing stone fragments is inserting
a basket device through a port on the ureteroscope, encapsulating individual stone fragments, and
manually removing the device. This device requires multiple insertions to remove the stone
fragments, as it is only capable of removing one or two fragments at a time, resulting in a longer
procedure time. There is a need for a kidney stone extraction device that removes residual
kidney stone fragments of sizes 1.5 - 4mm in patients who undergo laser ureteroscopies
with only one insertion of the device. This device would increase productivity by allowing
for more procedures and thereby increasing hospital revenue.

3. Objectives
A list of design objectives were created such that any device fulfilling these objectives
could accomplish our goal of increased productivity. The objectives were created to allow us to
be free of form and function when coming up with ideas for our device. The most important
objectives are that the device is easy to use, efficient, and safe for the patient. The objective tree
is shown in Appendix 1.

Efficient
Since our device mainly focuses on increasing the efficiency of removing secondary kidney
stone fragments, our device would be unmarketable if it were less efficient than the commonly
used device. This objective mandates that our device remove the majority of secondary kidney
stone fragments in the ureter with only one insertion of the device, ultimately reducing the
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duration of the procedure. The reduction in procedure duration would allow for greater patient
throughput and more revenue for the hospital.

Safe
Patient safety is the most important thing. Therefore, we had to ensure that our device will not
cause any harm to the patient, and more specifically, to their ureter. We have to ensure that our
device is just as safe, if not safer, than the currently used device. Safety is a determinant of how
successful a hospital is and is often quantified by fast patient recovery time and a low
readmittance rate [27].

Easy to Use
It is crucial that our device is easy to use. Clinicians would not want to learn how to use a new
and very complicated device when the commonly used device is simple and works well enough.
Thus, our device would not be marketable. Likewise, increased complexity could cascade into
the other elements of our project. These problems include a drop in efficiency, due to the
learning curve associated with the device, and a decrease in safety, since the procedure would
last longer allowing for increased contact between the ureter and device.
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4. Device Functions & Specifications
The functions and specifications for our device are based off of the overall goals we want
our device to accomplish and how the device will achieve these goals. A complete overview of
the functions and specifications associated with our device can be found in Appendix 2.
The result of performing a ureteroscopic holmium laser lithotripsy on a single kidney
stone located in the ureter is the generation of more, but smaller, secondary kidney stone
fragments. These secondary stone fragments can migrate while the main kidney stone is being
fragmented, causing the fragments to move either upstream or downstream of the ureter and also
potentially entering the bladder.
The main goal of our device is to remove and securely hold onto the majority of
secondary kidney stone fragments in the ureter. Securing the stone fragments would reduce their
chances of escaping from the device and entering the bladder, which could cause postoperative
pain and/or complications. Thus, the main function of our device is to gather, ideally, all of the
stone fragments, ranging from 1.5 mm - 4 mm in size, arising from the fragmentation of a kidney
stone in the ureter.
The limitation of commonly used extraction devices is that they are only capable of
removing a single kidney stone fragment at a time, requiring multiple insertions of the device.
Alternatively, our device will be capable of removing multiple kidney stone fragments with only
one insertion of the device. This will increase the efficiency of the procedure while also reducing
its duration. A reduced procedure time could potentially increase the amount of procedures
occurring in the hospital, therefore increasing hospital revenue. Additionally, the capability of
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removing multiple stone fragments with only one insertion of the device makes the procedure
safer. Since the device is only inserted once, this decreases the interaction between the device
and the ureter, reducing the possibility of damage to the ureter.
Lastly, our device will also be able to fit inside the working channel of the ureteroscope,
which is approximately 3.6 Fr [5]. The ureteroscope provides clinicians visualization of the
ureter and kidney stone so that they can accurately locate and rupture the stone.

5. Design Requirements
There are three design requirements that drove our solution to the problem. The first
requirement is that the device must contain the stone fragments throughout the entirety of the
removal process. This means that once the device has encapsulated the fragments in the ureter,
they must remain within the device while the device is pulled through the ureter and out of the
bladder. If our device is unable to accomplish this task, then it does not solve the problem of the
current devices.
The second design requirement is that the two baskets must be placed on two separate
wires within the same sheath. This requirement ensures that the two NTrap nets can deploy
independently of each other. Using the handle with this mechanism, each wire can be
manipulated to deploy each net into or out of the single sheath without affecting the movement
of the other net. Therefore, the distance between the nets is adjustable which allows the
fragments to become entrapped within the two nets.
The final design requirement is that the basket must have more room to contain the
fragments. In the current basket, the wires get compressed around the fragments, but it is only
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capable of gathering one or two stones at time as the majority of the stones fall through the gaps
between the wires. In order to prevent this issue, our device must have baskets that can hold
multiple fragments which would allow more fragments to be collected and removed at once. This
design requirement works in tangent with the first requirement since the shape of the nets
determine the ability of the device to capture all of the fragments.

6. Documentation of the Proposed Design
6.1 Simplified Overview
The overview of the purpose of our device is outlined in the objectives and design
requirements sections.
Our device is an innovation on the currently used handle and utilizes two NTraps [16].
While the nets of our device are constrained within the sheath, i.e. in their ‘off’ position, the
sheath is able to be pushed around the unfragmented kidney stone located in the ureter, shown
below in Figure 6.

Figure 6: Our device in its ‘off’ position, i.e. both nets are constrained within in the sheath, and is pushed around a
kidney stone located in the ureter.
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Then, the first net will be deployed. The two positions, being the ‘off’ position of the device and
the deployment of the first net, are shown below in Figure 7.
(a)

(b)

Figure 7: a) The two NTrap nets are constrained within the sheath and the device is in its ‘off’ position [17]. b) The
top NTrap net (concave down) deployed from sheath [18].

A holmium laser will then be used to rupture the main kidney stone into smaller fragments. The
deployed net will prevent these fragments from traveling upstream in the ureter, as shown below
in Figure 8.

Figure 8: Top net is deployed right before the holmium laser ruptures the main kidney stone into smaller fragments.
Deployed top net is used to prevent upstream migration of kidney stone fragments in the ureter.
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After the kidney stone has been completely fragmented, the laser is removed and the second net
is deployed to encapsulate all of the stone fragments, shown below in Figure 9.

Figure 9: Second NTrap net (concave up) deployed from the sheath. Both nets are now deployed and the device is in
its ‘on’ position.

We had to incorporate two NTrap nets with opposite orientations in order for our device to
securely encapsulate the stone fragments. Combining these opposite orientations creates a
capsule that is capable of holding all the fragments at once.
These two nets move independently of each other so that the user can manually control
the distance between them. This is achieved by having two separate nets on two separate wires
that are controlled by two buttons, shown below in Figure 10.
(a)

(b)

Figure 10: (a) Sketch of our handle showing the connection between the buttons and the nets. (b) Image of the top
side of our actual handle.

14

After the second net has been deployed, it is pushed as close to the first net as possible, securely
gathering all of the fragments. Once all of the fragments are collected, the nets stay pushed
together and the entire device is pulled out of the ureter, moving through the bladder, and is
removed from the body bringing all of the fragments along with it. A patent that inspired our
design solution can be found in Appendix 3.

6.2 Design Description
Our handle consists of four parts: a long half cylindrical tube with a full cylinder at the
end, a short cylindrical tube, the main body of the handle, and two triangular-shaped buttons.
The four parts of the handle are shown below in Figure 11.
(a)

(b)

Figure 11: a) From left to right: Short cylindrical tube, long half cylindrical tube with a full cylinder at the end, and
the main body of the handle. b) Triangular shaped buttons that go into the short cylindrical tube and the long half
cylindrical tube.
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The long, half cylindrical tube is used to control the deployment of the first NTrap, which
is concave down. On the commonly used basket device, there is a sheath that slides back and
forth over the basket, controlling its deployment, shown below in Figure 12.

Figure 12: Sheath slides back and forth over the basket, controlling its deployment [15].

The same type of sheath is used within our device and is attached to this long, half cylindrical
tube, shown below in Figure 13.
(a)

(b)

Figure 13: (a) Sheath attached to the end of the long, half cylindrical tube on our device. (b) Zoomed-in version of
(a).
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The sheath is inserted into the part of the tube that is a full cylinder. The half cylindrical portion
of this tube is located inside the main body of the handle and the full cylindrical portion is
outside the main body of the handle, shown above in Figure 13. There is also a button on top of
this internal tube so that when the user holds the handle they can slide the button with their
thumb, sliding the tube and moving the sheath, shown below in Figure 14.
(a)

(b)

Figure 14: Mechanism behind deployment of top net. (a) Top net is deployed by sliding the button back, retracting
the sheath and allowing the net to deploy. (b) Top net is constrained by sliding the button forward, pushing the
sheath over the net, causing it to become constricted within the sheath.

The short cylindrical tube is used to control the deployment of the second NTrap, which
is concave up, shown below in Figure 15. The second NTrap is also located within the sheath but
alternatively is moved in and out of the sheath by the short cylindrical tube.
(a)

(b)
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Figure 15: Mechanism behind deployment of bottom net. (a) Bottom net is deployed by sliding the button forward,
pushing the net out of the sheath, allowing it to expand and deploy. (b) Bottom net is constrained by sliding the
button back, pulling the net into the sheath, causing it to become constricted.

The wire that the top NTrap is attached to is fixed to the back of the main part of the
handle and the wire that the bottom NTrap is attached to is fixed to the back of the short
cylindrical tube. An overview of how both wires are fixed within the handle is shown below in
Figure 16.

Figure 16: Sketch of the locations of both wires in the handle. The wire connected to the top net, shown in purple, is
inside of the end of the long, half cylindrical tube and is fixed externally on the back of the handle. The wire
connected to the bottom net, shown in pink, is inside of the small cylindrical tube and is fixed to the back of this
small tube, which is located inside the handle. Wire clamps are used to securely hold the wires in place.

The short cylindrical tube has two small holes that run through the entire tube. One hole is used
to provide a path for the wire of the top NTrap to be fixed at the end of the main body. The
second hole is used to fix the wire of the bottom NTrap to the small tube. This tube is also
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located within the main body of the handle and lies right below the half cylindrical tube. An
overview of these small holes is shown below in Figure 17.

Figure 17: Location of small holes that allow the two wires, which are connected to the top and bottom nets, to be
fixed to the back of the main body of the handle and the short cylindrical tube, respectively.

6.3 Procedure
First, while both nets are constrained within the sheath, the sheath will be inserted
through a port on the ureteroscope and pushed around the unfragmented kidney stone located in
the ureter, shown above in Figure 6.
Secondly, using the handle, the first net is deployed by pulling the top button back
towards your body, shown above in Figure 14 (a). This retracts the sheath, allowing the first net
to move out of the sheath and expand to its original shape. Once the first net is deployed, a
holmium laser is inserted through a secondary port on the ureteroscope and is activated to
rupture the kidney stone, shown above in Figures 4 & 8. Since the first net is blocking the
upstream portion of the ureter, this prevents upstream migration of the secondary fragments, also
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shown above in Figure 8. Once the kidney stone has been completely fragmented, the laser is
removed from the ureteroscope.
Thirdly, using the handle, the second net is deployed by pushing the bottom button away
from you, shown above in Figure 15 (a). This directly pushes the second net out of the sheath,
allowing it to expand to its original shape. The same button is pushed further to bring the second
net as close to the first net as possible, encompassing the fragments.
Lastly, once the two nets have securely gathered the majority of the fragments, the
device, along with the fragments, are removed from the ureter, traveling through the bladder, and
eventually removed from the body.

7. Validation of Design
7.1 Testing requirements
The purpose of testing our device was to show that we successfully met our objectives
and functions. The most important objective we wanted to test was efficiency, therefore we
created a test that would compare the efficiency of our device versus the basket device versus the
NTrap. We will test the efficiency of these devices by calculating the percent of beads removed
from a tube with one insertion of each device. By completing this test, we were hoping to see our
device perform better than its competitors, and ideally capture and remove every bead from the
testing apparatus.
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7.2 Testing procedure
Our testing apparatus consisted of a plastic tube, 7mm in diameter, to mimic the ureter
and a tennis ball to mimic the bladder, shown in Figure 18. Beads of sizes 2 mm, 3 mm and 4
mm were used to mimic varying sizes of kidney stone fragments. We performed tests with five
beads of each size and one group of five randomly selected sizes. Each test was performed three
times using each device by two different operators. The basket, NTrap, and our device were each
inserted into the apparatus through the tennis ball. They were then navigated to the beads, and
when in position they were deployed from the sheath. The operator then collected as many beads
as possible and attempted to remove them from the apparatus. Once the device was removed, the
number of beads that remained in the apparatus was collected. This data was then recorded in
Excel to calculate the percent of stones collected for each device. There were no reinsertions of
the device on any test to maintain consistency. A table representing the data collection is shown
in Appendix 4.

Figure 18: The testing apparatus consists of the 7mm diameter tube to mimic the ureter, the tennis ball to mimic the
bladder, and the beads to mimic the fragments.
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7.3 Data analysis
Our data analysis consisted of comparing the number of stones collected by each device
and recording that as a percentage. The percentages were then averaged for each test group and
were organized into a bar graph, shown in Figure 19.

Figure 19: A bar graph representing the ability of the three different devices to remove kidney stones. The size of the
stones tested is shown on the x-axis, and the average percentage of stones collected across all tests is shown on the
y-axis. It can be seen that the basket device operated better at larger sizes than the NTrap. There is limited data for
our device due to mechanical complications that limited our testing capabilities.

The graph shows that the NTrap and wire basket devices both have a collection rate below 50%,
while our device had a collection rate of 93% when tested, therefore our basket device was more
efficient in removing multiple beads. It should be noted that testing data for our device was
incomplete due to mechanical issues with the baskets during testing. This was a result of relying
on modified existing baskets that would get tangled up with each other. A future task that should
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be pursued is to manufacture the bottom net the way we oriented it in the prototype in order to
prevent these complications.
Another important observation we gathered from the test is the location of where each
device left stone fragments within the apparatus. We found that the NTrap left beads behind in
the tennis ball whereas the wire basket left beads behind in the tube. This suggests that the NTrap
is efficient at removing multiple stones from the ureter whereas the basket device struggles with
removing multiple stones from the ureter. It also suggests the NTrap struggles with containing
the fragments in the bladder whereas the basket device is able to contain the fragments in the
bladder. This observation is important because with the basket of the NTrap allowing for
efficient removal from the ureter and the inclusion of the second inverse basket helping to
contain fragments in the bladder, our device managed to solve the challenges with the two
current devices. Therefore, the test provides substantial evidence that our device is the most
efficient in removing multiple stone fragments out of the three devices that were tested.

8. Anticipated Regulatory Pathway
8.1 Device Classification
Under FDA classifications, a class 2 device is any device that interacts within the body
but is not at high risk for causing severe health issues if malfunction occurs [21]. Since our
device enters the body but is not life preserving, it meets Class 2 device regulation. Thus, for
FDA approval, our device would have to go through the 510(k) review process [21].
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8.2 Types of 510(k)'s
There are three main types of 510(k) processes. These include the traditional,
abbreviated, and special 510(k) [26]. Each one differs in the required testing and time needed to
get approval.
The traditional 510(k) is the oldest version of the 510(k) process [26]. The most
important requirements for the traditional 510(k) include the cover letter, device description, and
the discussion of substantial equivalence which includes the intended use of the device [19]. The
traditional 510(k) has a review time of 90 days after submission [19].
The abbreviated 510(k) is similar to the traditional 510(k) since it also has a 90 day
review time but was created in an attempt to streamline the process by reducing the amount of
testing required for the manufacturer [19]. One would submit an abbreviated 510(k) when they
are relying on FDA guidance documents, compliance with special device controls in guidance
documents, or voluntary consensus standards [19]. The abbreviated 510(k) allows a company to
show that they have met a set of standards that is already in place by the FDA or an outside
standards regulator.
Lastly, the special 510(k) has a shorter review period of 30 days since it is used when
there are proposed changes to an existing device [24].

8.3 Deciding on the 510(k) and Premarket Notification
Deciding to use the correct type of 510(k) can be extremely important in saving time and
gaining approval. To help with this process, the manufacturer can send a 513(g) request, which
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asks the FDA to help determine the class of the device and the appropriate 510(k) to use [25].
After choosing the appropriate 510(k) path, a premarket notification can be sent in to the FDA 90
days before the device's intended market date, starting the review process [19, 24, 26]. For our
device, there does not appear to be a clear set of standards on the testing of kidney stone removal
devices. Thus, the traditional 510(k) process is the desired pathway for our device.

8.4 Testing
A common form of premarket testing for kidney stone removal devices is the use of the
porcine urinary tract [20]. By testing the device in a porcine urinary tract, relevant data
pertaining to stone collection capability and capacity, time of use, and damage to the tissue can
be observed. With this data, a company or testing facility would know if they could confidently
enter human testing as well as the FDA approval process.

8.5 Substantial Equivalence
Substantial equivalence is required for the 510(k) process, which is the ability to show
that a new device is similar to a device that has already been FDA approved [22]. Our device
meets substantial equivalence since it incorporates modifications of two different devices.
The first modification is the handle. This modification is simple and adds no new risk to
the procedure. If the handle modification was the only modification that was made, our device
would have an increased chance at passing a special 510(k).
The second modification is the basket. Although the two baskets are already FDA
approved devices, the addition of the second basket could result in unforeseen complications.

25

Providing data that shows the addition of a second NTrap will not cause harm to the patient,
alongside already approved devices such as the NTrap and commonly used basket, our device
would be substantially equivalent to pre-existing kidney stone removal devices [16, 23].
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Appendix 1: Objective Tree

Shown in Appendix 1 is our weighted objective tree. It outlines all of the objectives that we considered most
important and how we weighted each one. The tree is split into the categories of safe and marketable. Since safety is
always required when designing a medical device we focused more heavily on the marketability side when
brainstorming design solutions. Under marketable we identified five main categories. When weighting the
categories, efficient and easy to use were weighted heavier than the others as we figured they were the most
important in creating a successful and marketable device. Efficient is split up into two more categories involving low
patient risk and treatment of multiple stones. Both are weighted heavily as they are both essential to our devices
proper operation.
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Appendix 2: Functions and Specifications
TABLE 1:
Required functions of the kidney stone removal device with its corresponding marginal and ideal values.

Function

Metric

Unit

Marginal Value

Ideal Value

Gathers stone
fragments

Size of stone

Millimeters (mm)

4 mm [4]

1.5 mm [13]

Holds stone
fragments

Percent of
fragments
removed

Percentage (%)

80%

100%

Safe

Damage of tissue

Binary: yes or no

Operates
efficiently

Amount of times
entering/exiting
ureter

Number

2 times

1 time

3.6 Fr

3 Fr

Collapses into
ureteroscope
Fits in
ureteroscope

Binary: yes or no
Size of port on
ureteroscope

Fr (French Gauge)
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Appendix 3: Patent

Shown in Appendix 3 is a relevant patent that we found, which inspired our current design solution. This device was
made to be used during a non-invasive kidney stone removal procedure. This device incorporates two balloons,
which are shown by 26 and 28 in figure 1, and has a port for a guide wire and for each balloon, which are shown by
30, 36 and 38 in figure 2, respectively. During the procedure, a guide wire would be pushed around a kidney stone
located within the ureter, shown in figure 4. Then, while the balloons are deflated, the device would be pushed over
the guide wire so that the balloons are on either side of the stone, shown in figure 5. The balloons would then be
inflated using the ports. This is to block the up and downstream parts of the ureter. Ultrasonic waves would then be
used externally to rupture the stone, shown in figure 6. Once the stone has been ruptured, the bottom balloon would
be deflated and irrigation would be used to flush out the stones. However, the top balloon stays inflated to prevent
any fragments from traveling farther up the ureter, shown in figure 7. Once this is finished, the top balloon would be
deflated and the device would be removed from the body.
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Appendix 4: Testing Table
TABLE 2:
A table representing how the trials were performed and how the data was organized. Each test is performed three
times per user. Five beads were used for each trial and then the final amount of beads corresponds to the number of
beads left in either the tube or the tennis ball. The average percent was calculated
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